NEFL and Alzheimer disease: One potential blood-based biomarker for AD is the neuronal injury marker neurofilament light (NFL) because patients with AD have increased CSF concentrations of NFL. Results from some studies suggest that patients with AD have increased plasma NFL concentrations.